Dr. Saveen Semage re-appointed as CEO of NMRA
The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- India extends LTTE ban for another 5 years May 14, 2024
- U.S. Officials discuss Sri Lanka’s economic and security issues with NPP May 14, 2024
- Sri Lanka’s health trade unions launch strike across Sabaragamuwa Province hospitals May 14, 2024
- Sri Lanka Government ready to raise estate worker wages despite company objections May 14, 2024
- U.S. Assistant Secretary Donald Lu meets with Sri Lankan President May 13, 2024